Weill David 4
4 · TransMedics Group, Inc. · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Weill David
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-03$14.20/sh+5,000$71,000→ 17,134 total - Sale
Common Stock
2025-12-03$138.64/sh−5,000$693,200→ 12,134 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-03−5,000→ 5,000 totalExercise: $14.20Exp: 2030-06-04→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option is fully vested.